Cargando…

Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids

Non-alcoholic steatohepatitis (NASH) is known to progress to cirrhosis and hepatocellular carcinoma in some patients. Although NASH is associated with abnormal mitochondrial function related to lipid metabolism, mechanisms for the development and effective treatments are still unclear. Therefore, ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbadawy, Mohamed, Tanabe, Kiwamu, Yamamoto, Haru, Ishihara, Yusuke, Mochizuki, Maria, Abugomaa, Amira, Yamawaki, Hideyuki, Kaneda, Masahiro, Usui, Tatsuya, Sasaki, Kazuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600465/ https://www.ncbi.nlm.nih.gov/pubmed/37900170 http://dx.doi.org/10.3389/fphar.2023.1243258

Ejemplares similares

Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids
por: Abugomaa, Amira, et al.
Publicado: (2023)

Development of Prostate Cancer Organoid Culture Models in Basic Medicine and Translational Research
por: Elbadawy, Mohamed, et al.
Publicado: (2020)

Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
por: Abugomaa, Amira, et al.
Publicado: (2020)

Effect of the liquid form of traditional Chinese medicine, Hozen-S, on gastric motility in dogs
por: SHINOHARA, Yuta, et al.
Publicado: (2022)

Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture
por: Abugomaa, Amira, et al.
Publicado: (2020)

Establishment of Intestinal Organoid from Rousettus leschenaultii and the Susceptibility to Bat-Associated Viruses, SARS-CoV-2 and Pteropine Orthoreovirus
por: Elbadawy, Mohamed, et al.
Publicado: (2021)

Oral pharmacokinetics of sulfadiazine and sulfamonomethoxine in female Holstein milking cows
por: TAJIMA, Tsuyoshi, et al.
Publicado: (2023)

Development of an Experimental Model for Analyzing Drug Resistance in Colorectal Cancer
por: Elbadawy, Mohamed, et al.
Publicado: (2018)

Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals
por: Elbadawy, Mohamed, et al.
Publicado: (2018)

Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
por: Elbadawy, Mohamed, et al.
Publicado: (2019)

Correction: Elbadawy, M., et al. Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals. Int. J. Mol. Sci. 2018, 19, 3031
por: Elbadawy, Mohamed, et al.
Publicado: (2020)

Evaluation of the Safety and Feasibility of Apheresis in Dogs: For Application in Metastatic Cancer Research
por: Yamamoto, Haru, et al.
Publicado: (2021)

Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture
por: Usui, Tatsuya, et al.
Publicado: (2018)

Mdivi-1 and mitochondrial fission: recent insights from fungal pathogens
por: Koch, Barbara, et al.
Publicado: (2019)

Pharmacokinetics of Tylvalosin in Broiler Turkeys (Meleagris Gallopavo) After Single Intravenous and Oral Administration
por: Elbadawy, Mohamed, et al.
Publicado: (2019)

Mdivi-1, mitochondrial fission inhibitor, impairs developmental competence and mitochondrial function of embryos and cells in pigs
por: YEON, Ji-Yeong, et al.
Publicado: (2014)

Establishment of a novel experimental model for muscle‐invasive bladder cancer using a dog bladder cancer organoid culture
por: Elbadawy, Mohamed, et al.
Publicado: (2019)

Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis
por: Li, Yan-Hua, et al.
Publicado: (2019)

Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
por: Horn, Christian L., et al.
Publicado: (2021)

The burden of nonalcoholic steatohepatitis (NASH) in the United States
por: Tapper, Elliot B., et al.
Publicado: (2023)

A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH
por: Takayama, Fusako, et al.
Publicado: (2009)

Inhibition of DRP1-dependent mitochondrial fission by Mdivi-1 alleviates atherosclerosis through the modulation of M1 polarization
por: Su, Ze-da-zhong, et al.
Publicado: (2023)

Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction
por: Simon, Tracey G., et al.
Publicado: (2017)

Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)
por: Qi, Xiaoyan, et al.
Publicado: (2022)

The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2016)

Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
por: Kutlu, Ozlem, et al.
Publicado: (2018)

A new method to induce nonalcoholic steatohepatitis (NASH) in mice
por: Savari, Feryal, et al.
Publicado: (2019)

Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
por: Lee, Jin Ha, et al.
Publicado: (2020)

Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
por: Sharma, Mithun, et al.
Publicado: (2021)

Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment
por: Ilan, Yaron
Publicado: (2018)

Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH)
por: Kaur, Savneet, et al.
Publicado: (2019)

Biliary excretion and pharmacokinetics of several fluoroquinolones after intravenous injection in rabbits
por: SHIMADA, Sumire, et al.
Publicado: (2023)

Targeting Mitochondrial Fission Using Mdivi-1 in A Clinically Relevant Large Animal Model of Acute Myocardial Infarction: A Pilot Study
por: Ong, Sang-Bing, et al.
Publicado: (2019)

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
por: Yoneda, Masato, et al.
Publicado: (2008)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
por: Takaki, Akinobu, et al.
Publicado: (2014)

Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients
por: Losekann, Alexandre, et al.
Publicado: (2015)

Population Pharmacokinetics of Morphine in Patients With Nonalcoholic Steatohepatitis (NASH) and Healthy Adults
por: Pierre, V, et al.
Publicado: (2017)

Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH)
por: Min-DeBartolo, Jessica, et al.
Publicado: (2019)

Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH)
por: Hartimath, S. V., et al.
Publicado: (2019)

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)
por: Vandel, Jimmy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0embqmtnlut32j10bjc3edog6o